Evidence status: CURRENT AUTHORITY AND CHANGE-PATH RECORD. Connecticut’s agreement-or-care-plan requirement is written directly into CGS §20-14s. Removing or materially narrowing the statewide requirement therefore requires legislative amendment.

Primary legislative route

The Connecticut General Assembly controls the statutory mandate. The joint standing Public Health Committee has jurisdiction over the Department of Public Health, controlled substances, health licensing boards, and related health policy.

Current Public Health Committee co-chairs

Chamber Current co-chair
Senate Sen. Saud Anwar
House Rep. Cristin McCarthy Vahey

Department of Public Health

The current Commissioner of Public Health is Manisha Juthani, MD. DPH oversees the Connecticut Medical Examining Board and other health-profession regulatory functions but does not have unilateral authority to repeal §20-14s.

Department of Consumer Protection

The current Commissioner of Consumer Protection is Bryan T. Cafferelli. DCP’s Drug Control Division administers controlled-substance registration and the prescription-monitoring system and publishes current prescribing guidance, but DCP cannot repeal the statutory agreement/care-plan requirement.

Connecticut Medical Examining Board

The current Board Chair is Kathryn Emmett, Esq. The Board may enforce physician standards and issue professional guidance within its authority, but it did not enact §20-14s and cannot repeal it administratively.

What must change

A clean repeal or narrowing of Contract for Care in Connecticut must amend the language in CGS §20-14s that requires an agreement or chronic-opioid care-plan discussion after more than 12 weeks of opioid treatment for pain.

Primary sources

Reviewed: October 4, 2026.

Evidence boundary: Administrative agencies and licensing boards can shape implementation and enforcement, but only the General Assembly can repeal or amend the statutory mandate itself.